Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | -72,985 | 348,086 | 48,429 | 1,936 | 4 |
| Operating Income | 72,985 | -348,086 | -48,429 | -1,936 | -4 |
| Other Income | -30,980 | -36,546 | -4,127 | 10,137 | 0 |
| Pre-tax Income | 42,005 | -384,632 | -52,556 | 8,201 | -4 |
| Net Income Continuous | 42,005 | -384,632 | -52,556 | 8,201 | -4 |
| Net Income | $42,005 | $-384,632 | $-52,556 | $8,201 | $-4 |
| EPS Basic Total Ops | 77.74 | -745.41 | -27.34 | 18.71 | 0.00 |
| EPS Basic Continuous Ops | 77.79 | -745.41 | -27.23 | 86.67 | -0.04 |
| EPS Diluted Total Ops | 72.93 | -745.41 | -27.34 | 18.71 | 0.00 |
| EPS Diluted Continuous Ops | 72.93 | -745.41 | -27.23 | 86.67 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -34.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $73,082 | $-347,987 | $-48,361 | $-1,936 | $-4 |